Banner Health's insurance plan integrates health system data and AI technology to improve care coordination, compliance, and member experience in Medicare and Medicaid markets.

Atlantic American reports Q3 net income of $0.6M, reversing prior loss with growth in premium revenue and unrealized investment gains across key insurance lines.

Elevance Health stock appears undervalued based on discounted cash flow and P/E ratio analyses amid ongoing healthcare reforms and Medicare Advantage shifts. Learn key valuation insights for U.S. health insurance market investors.

Medicare Advantage plans are advancing outcomes by integrating clinical excellence, AI-driven engagement, health literacy, and community partnerships to support holistic member care.

Explore how rural hospitals are adapting to Medicaid cuts and workforce challenges through innovation and targeted strategies to maintain healthcare access in rural America.

Novo Nordisk and Eli Lilly agree to lower GLP-1 drug prices in exchange for expanded Medicare and Medicaid coverage, marking a major shift in U.S. drug pricing and access.

The 2026 Medicare home health final rule release is delayed due to the government shutdown. Proposed 9% reimbursement cuts spark industry-wide concern and strategic responses from key providers and advocacy groups.

CMS issues National Coverage Determination for FDA-approved renal denervation treatment under Coverage with Evidence Development for uncontrolled hypertension in Medicare patients.

Stellar Health's MSSP ACO surpasses Medicare average savings with $5M saved in 2024, leveraging tech-enabled micro-incentives to improve provider performance and patient outcomes in value-based care.

Explore how political donations and regulatory delays have impacted Medicare coverage and spending on costly skin substitute products lacking scientific validation.